Get the Stockscreener App
6.965
2.96%
0.205
Teladoc Health Inc stock is traded at $6.965, with a volume of 3.03M.
It is up +2.96% in the last 24 hours and down -19.63% over the past month.
Teladoc Health Inc is engaged in virtual care, forging a new healthcare experience with improved convenience, outcomes, and value. Its mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems.
See More
Previous Close:
$6.76
Open:
$6.76
24h Volume:
3.03M
Relative Volume:
0.41
Market Cap:
$1.23B
Revenue:
$2.54B
Net Income/Loss:
$-207.36M
P/E Ratio:
-5.8529
EPS:
-1.19
Net Cash Flow:
$151.25M
1W Performance:
+0.58%
1M Performance:
-19.63%
6M Performance:
-0.14%
1Y Performance:
-33.08%
1-Day Range:
$6.73
$7.05
1-Week Range:
$6.58
$7.34
52-Week Range:
$6.35
$15.21
Teladoc Health Inc Stock (TDOC) Company Profile
Name
Teladoc Health Inc
Sector
Industry
Phone
(203) 635-2002
Address
155 E 44TH STREET, NEW YORK, NY
Compare TDOC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
6.955 | 1.20B | 2.54B | -207.36M | 151.25M | -1.19 |
|
VEEV
Veeva Systems Inc
|
241.87 | 44.34B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
68.86 | 11.69B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
102.26 | 8.68B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
50.12 | 8.74B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
35.57 | 6.66B | 906.14M | -52.62M | 89.62M | -0.3621 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Jul-25-25 | Initiated | Mizuho | Neutral |
| Nov-15-24 | Initiated | Goldman | Buy |
| Sep-17-24 | Reiterated | Jefferies | Hold |
| Feb-29-24 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-17-24 | Downgrade | DA Davidson | Buy → Neutral |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Feb-23-23 | Upgrade | SVB Securities | Market Perform → Outperform |
| Oct-24-22 | Upgrade | Guggenheim | Sell → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-17-22 | Downgrade | Guggenheim | Neutral → Sell |
| Aug-12-22 | Initiated | DA Davidson | Buy |
| Aug-02-22 | Downgrade | Berenberg | Buy → Hold |
| Aug-02-22 | Downgrade | Cowen | Outperform → Market Perform |
| Jul-28-22 | Downgrade | Goldman | Buy → Neutral |
| Jul-28-22 | Downgrade | Needham | Buy → Hold |
| Jul-06-22 | Reiterated | BofA Securities | Neutral |
| May-05-22 | Downgrade | Argus | Buy → Hold |
| Apr-28-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-28-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-28-22 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-28-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-28-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-28-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-28-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-03-22 | Upgrade | Argus | Hold → Buy |
| Feb-23-22 | Reiterated | BofA Securities | Neutral |
| Feb-23-22 | Reiterated | Craig Hallum | Hold |
| Feb-23-22 | Reiterated | Evercore ISI | In-line |
| Feb-23-22 | Reiterated | Goldman | Buy |
| Feb-23-22 | Reiterated | JP Morgan | Overweight |
| Feb-23-22 | Reiterated | KeyBanc Capital Markets | Overweight |
| Feb-23-22 | Reiterated | Needham | Buy |
| Feb-23-22 | Reiterated | Oppenheimer | Outperform |
| Feb-23-22 | Reiterated | Stifel | Hold |
| Feb-11-22 | Initiated | Goldman | Buy |
| Feb-08-22 | Reiterated | Piper Sandler | Overweight |
| Dec-02-21 | Resumed | Jefferies | Hold |
| Nov-22-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-28-21 | Reiterated | Barclays | Equal Weight |
| Oct-28-21 | Reiterated | BofA Securities | Neutral |
| Oct-28-21 | Reiterated | Canaccord Genuity | Buy |
| Oct-28-21 | Reiterated | Citigroup | Buy |
| Oct-28-21 | Reiterated | Craig Hallum | Hold |
| Oct-28-21 | Reiterated | Needham | Buy |
| Oct-28-21 | Reiterated | Oppenheimer | Outperform |
| Oct-28-21 | Reiterated | Piper Sandler | Overweight |
| Oct-28-21 | Reiterated | UBS | Neutral |
| Oct-19-21 | Initiated | Wells Fargo | Overweight |
| Aug-02-21 | Downgrade | Argus | Buy → Hold |
| Jul-28-21 | Downgrade | Deutsche Bank | Buy → Hold |
| May-28-21 | Initiated | Robert W. Baird | Neutral |
| Apr-15-21 | Initiated | Needham | Buy |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Dec-22-20 | Initiated | Evercore ISI | In-line |
| Dec-07-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| Dec-04-20 | Initiated | Goldman | Neutral |
| Nov-13-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-22-20 | Initiated | DA Davidson | Buy |
| Sep-02-20 | Upgrade | Berenberg | Hold → Buy |
| Aug-17-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jul-13-20 | Initiated | Argus | Buy |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Apr-30-20 | Reiterated | KeyBanc Capital Markets | Overweight |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Mar-31-20 | Downgrade | Berenberg | Buy → Hold |
| Mar-25-20 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-16-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-12-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-28-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-12-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-10-20 | Initiated | UBS | Neutral |
| Jan-09-20 | Downgrade | BofA/Merrill | Buy → Neutral |
View All
Teladoc Health Inc Stock (TDOC) Latest News
Does Teladoc's Acquisition Strategy Boost Growth and Global Footprint? - Yahoo Finance
Why Teladoc Health Inc. (4LL) stock could rally stronglyMarket Sentiment Review & Risk Adjusted Buy/Sell Alerts - newser.com
Is Teladoc Health Inc. stock attractive post correctionAnalyst Downgrade & Risk Controlled Daily Plans - newser.com
Teladoc and Netflix Shares Are Falling, What You Need To Know - Yahoo Finance
TDOC vs. LFMD: Which Telehealth Stock Is Better for Your Portfolio? - sharewise.com
Could TytoCare Collaboration Reveal Shifts in Teladoc Health's (TDOC) Virtual Care Strategy? - Yahoo Finance
Why pension funds invest in Teladoc Health Inc. (4LL) stock2025 Performance Recap & Step-by-Step Swing Trade Plans - newser.com
Why Teladoc Health Inc. stock trades below fair valueJuly 2025 Weekly Recap & High Conviction Buy Zone Alerts - newser.com
Will Teladoc Health Inc. stock benefit from upcoming earnings reportsWeekly Market Report & Growth Focused Stock Reports - newser.com
Online Marketplace Stocks Q3 Highlights: Teladoc (NYSE:TDOC) - Finviz
Will Teladoc Health Inc. stock sustain uptrend momentumMarket Sentiment Report & Technical Pattern Alert System - newser.com
How Teladoc Health Inc. (4LL) stock compares with top peers2025 Price Momentum & Low Drawdown Investment Ideas - newser.com
Why Teladoc Health Inc. stock could outperform next yearDividend Hike & Smart Money Movement Alerts - newser.com
Is Teladoc Health Inc. stock attractive for growth fundsRate Hike & Low Risk Investment Opportunities - newser.com
How to integrate Teladoc Health Inc. into portfolio analysis tools2025 Major Catalysts & High Yield Equity Trading Tips - newser.com
Can Teladoc Health Inc. stock stage a strong rebound this quarterJuly 2025 Opening Moves & Expert Curated Trade Setups - newser.com
Is Teladoc Health Inc. stock cheap at current valuationInsider Selling & Real-Time Stock Movement Alerts - newser.com
How Teladoc Health Inc. (4LL) stock behaves under inflation pressureMarket Risk Analysis & Weekly Watchlist of Top Performers - newser.com
Can Teladoc Health Inc. (4LL) stock reach $200 price targetJuly 2025 Closing Moves & Weekly Top Gainers Alerts - newser.com
Is Teladoc Stock a Buy After Oracle Investment Management Upped Its Stake? - Yahoo Finance
Is Teladoc Health Inc. (4LL) stock nearing a technical breakoutJuly 2025 Sector Moves & Fast Entry and Exit Trade Plans - newser.com
TDOC Partners With TytoCare to Expand At-Home Exam Capabilities - TradingView
What to do if you’re stuck in Teladoc Health Inc.Market Performance Report & Growth Focused Investment Plans - newser.com
Will Teladoc Health Inc. stock gain from strong economyMarket Growth Report & Community Consensus Stock Picks - newser.com
Empire Life marks digital health week, announces myStrength™ by Teladoc Health Canada, expanding digital mental health tools for group benefits customers - Cantech Letter
How Teladoc Health Inc. stock performs in volatility spikesWeekly Stock Summary & Smart Money Movement Alerts - newser.com
Teladoc Health Inc Stock (TDOC) Financials Data
Revenue
Net Income
Cash Flow
EPS
10.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):